← Leaderboards
Sukyung Woo
State University Of New York At Buffalo
$2,668,332
Attributed
$2,668,332
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $416.9K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,668,332 · 2
By mechanism
R01$1,613,192 · 1
P20$1,055,140 · 1
Top collaborators
No co-investigators on record.
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Bruce J Nicholson$6,503,591
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyIn VivoMolecularDrug ResistanceResistancePre-Clinical ModelIn VitroMalignant NeoplasmsTumor ProgressionCessation Of LifeXenograft ProcedureAdvanced DiseaseTumorPathway InteractionsTumor MicroenvironmentCoculture TechniquesBaseAnticancer ResearchAging PopulationDesignAngiogenic FactorBevacizumabCytokineDocetaxel
Grant awards (9)
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition$393,267
R01 · FY2025 · CA · contact PI
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition$410,155
R01 · FY2024 · CA · contact PI
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition$392,820
R01 · FY2023 · CA · contact PI
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition$416,950
R01 · FY2022 · CA · contact PI
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)$204,739
P20 · FY2016 · GM · contact PI
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)$208,905
P20 · FY2015 · GM · contact PI
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)$212,999
P20 · FY2014 · GM · contact PI
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)$206,497
P20 · FY2013 · GM · contact PI
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)$222,000
P20 · FY2012 · GM · contact PI